Inovio director granted RSUs and stock options

INOVIO PHARMACEUTICALS director Wendy L. Yarno received new equity awards as part of her non-employee director compensation.

Rhea-AI Filing Summary

INOVIO PHARMACEUTICALS director Wendy L. Yarno received new equity awards as part of her non-employee director compensation. On May 20, 2026, she was granted 34,200 restricted stock units and options on 41,800 shares of common stock with a $1.23 exercise price.

The awards were granted under the 2023 Omnibus Incentive Plan. Both the restricted stock units and the stock options vest 100% on May 20, 2027, meaning they become fully earned on that date if service conditions are satisfied.

Insider Trade Summary

Grant/Award: 76,000 shares

Grant/Award 2 txns

Insider YARNO WENDY L

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock Options	41,800	$0.00	$0.00
Grant/Award	Restricted Stock Unit	34,200	$0.00	$0.00

Holdings After Transaction: Common Stock Options — 41,800 contracts (Direct); Restricted Stock Unit — 34,200 contracts (Direct)

Footnotes (3)

1. F1. This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy.
2. F2. Options to vest 100% on May 20, 2027.
3. F3. Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027.

Key Figures

Restricted stock units granted: 34,200 units Stock options granted: 41,800 options Option exercise price: $1.23 per share +5 more

8 metrics

Restricted stock units granted 34,200 units Grant to director Wendy L. Yarno on May 20, 2026

Stock options granted 41,800 options Grant to Wendy L. Yarno on May 20, 2026

Option exercise price $1.23 per share Common Stock Options granted May 20, 2026

Option expiration date May 20, 2036 Term of Common Stock Options

RSU vesting date May 20, 2027 Restricted Stock Units vest 100% on this date

Option vesting date May 20, 2027 Common Stock Options vest 100% on this date

RSUs held after grant 34,200 units Total RSUs following transaction

Options held after grant 41,800 options Total options following transaction

Key Terms

Restricted Stock Unit, Common Stock Options, 2023 Omnibus Incentive Plan, non-employee director compensation policy, +1 more

5 terms

Restricted Stock Unit financial

"Each restricted stock unit represents a contingent right to receive one share of common stock."

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

Common Stock Options financial

"Common Stock Options with an exercise price of $1.23 per share expiring May 20, 2036."

2023 Omnibus Incentive Plan financial

"This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy."

non-employee director compensation policy financial

"This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy."

vest 100% financial

"Options to vest 100% on May 20, 2027."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did INO director Wendy L. Yarno receive in this Form 4?

Wendy L. Yarno received 34,200 restricted stock units and options on 41,800 shares of INOVIO common stock. These awards were granted as part of the company’s non-employee director compensation under the 2023 Omnibus Incentive Plan.

What is the exercise price and term of Wendy Yarno’s new INO stock options?

The new stock options for Wendy Yarno cover 41,800 INOVIO shares at an exercise price of $1.23 per share. These options expire on May 20, 2036, providing a long-term incentive aligned with the company’s future performance.

When do Wendy Yarno’s INOVIO restricted stock units vest?

All 34,200 restricted stock units granted to Wendy Yarno vest 100% on May 20, 2027. Upon vesting, each unit represents the right to receive one share of INOVIO common stock, assuming applicable service conditions are met.

When do Wendy Yarno’s newly granted INO stock options vest?

The 41,800 INOVIO stock options granted to Wendy Yarno vest 100% on May 20, 2027. She may exercise them at $1.23 per share after vesting and before the expiration date, subject to the plan’s terms.

Under which plan were Wendy Yarno’s INOVIO equity awards granted?

Both the restricted stock units and stock options for Wendy Yarno were granted under INOVIO’s 2023 Omnibus Incentive Plan. The filing notes these grants were made pursuant to the company’s non-employee director compensation policy.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/21/2026 - 04:49 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

YARNO WENDY L

(Last) (First) (Middle)

660 W. GERMANTOWN PIKE

SUITE 110

(Street)

PLYMOUTH MEETING PENNSYLVANIA 19462

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
INOVIO PHARMACEUTICALS, INC. [ INO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock Options	$1.23	05/20/2026		A		41,800(1)		(2)	05/20/2036	Common Stock	41,800	$0	41,800	D
Restricted Stock Unit	(3)	05/20/2026		A		34,200(1)		(3)	(3)	Common Stock	34,200	$0	34,200	D

Explanation of Responses:

1. This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy.

2. Options to vest 100% on May 20, 2027.

3. Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027.

Remarks:

	/s/ Wendy Yarno	05/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)